Disease Control and Prevention Vaccine Market will grow at 12.1% CAGR, to be valued at US$ 102.54 Billion by 2025, Owing to high prevalence and increasing incidence of infectious disease are the major factors driving the growth of the market

Global Disease Control and Prevention Vaccine Market, by Product Type (Live-attenuated, Inactivated, Recombinant Sub Unit, and Toxoid), by Type (Monovalent and Multivalent), By Route of Administration (Oral and Injectable), by Age Group (Pediatric Vaccine and Adult Vaccine), and by Indication (Infectious Disease, Cancer, and Other Indications) is estimated to be valued at US$ 41.12 billion in 2017 and is estimated to exhibit a CAGR of 12.1% over the forecast period (2017-2025).  

Vaccine is a biological preparation that offer active acquired immunity to inhibit or control a particular disease or a group of disease. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control worldwide and is done in adults and infants. According to European Centre for Disease Prevention and Control (ECDC), pertussis and invasive pneumococcal disease account for over 50% of vaccine preventable disease and over 60% of deaths. The completion of immunization schedule from infant to adulthood decreases the burden of vaccine preventable disease significantly. According to the World Health Organization (WHO)’s, 2018 factsheet, immunization averts around 2 to 3 million deaths annually around the globe. Furthermore, according to the same source, around 1.5 million deaths can be prevented by improving vaccine coverage across the globe.

Get Your FREE Sample Copy of the Disease Control and Prevention Vaccine Market Report 2021

The increasing product launches by market players coupled with rising government immunization programs are the major factors that are expected to drive growth of the global disease control and prevention vaccine market over the forecast period. Moreover, vaccines aids in controlling and preventing viral and bacterial diseases. Vaccines for infectious disease plays an important role in reducing disease incidence and burden of vaccine preventable disease. For instance, according to the Centers for Disease Control and Prevention (CDC), 2013, around 226,000 people are hospitalized every year and around 3,000-49,000 people are reported to die due to influenza and its complications.

Moreover, global efforts are made to tackle infectious disease by better surveillance and immunization system. For instance, according to the World Health Organization (WHO), incidence of polio decreased by 99% in 2018 compared to 1988, which is attributed to global initiatives for polio eradication by public and private organizations. Furthermore, increasing government initiatives to strengthen immunization program are expected to further boost growth of the disease control and prevention vaccine market. For instance, in 2017, Minister of Health from 194 countries supported Global Vaccine Action Plan to prevent millions of death through more access to vaccine by 2020. Moreover, key players are focusing on developing new vaccines with low price offering better safety and immunity for the disease.

Browse 47 Market Data Tables and 45 Figures spread through 210 Pages and in-depth TOC on “Disease Control and Prevention Vaccine Market, by Product Type (Live-attenuated, Inactivated, Recombinant Sub Unit, and Toxoid), by Type (Monovalent and Multivalent), by Route of Administration (Oral and Injectable), by Age Group (Pediatric Vaccine and Adult Vaccine), and by Indication (Infectious Disease, Cancer, and Other Indications) – Global Forecast to 2025”.

To know the latest trends and insights related to disease control and prevention vaccine market press release

Additionally, key players in vaccine market are focusing on research and development to develop new vaccines with low cost, offering better safety and immunity for the disease and to expand their product portfolio. For instance, in 2017, GlaxoSmithKline plc, received the U.S. FDA approval for phase III clinical trial of its product Shingrix, a recombinant sub unit vaccine for shingles infection in adults. Moreover, manufacturers are focusing on developing vaccines by targeting diseases such as HIV or dengue to expand their product portfolio. For instance, Sanofi received the U.S. FDA approval for its dengue vaccine, Dengvaxia, in 2018.

Key players are also focusing on adopting growth strategies such as mergers and acquisitions, in order to strengthen their market position. For instance, in 2014, Pfizer Inc., acquired Baxter’s portfolio including marketed vaccines valued at US$ 648 million. The portfolio includes NeisVac-C and FSME-IMMUN/TicoVac vaccines against meningitis.

Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/1500

Reasons to Purchase this Report

• Current and future of global Disease Control and Prevention Vaccine market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

“Limited Time Offer”

Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/1500

Growing Prevalence of Infectious Diseases is Expected to Propel Growth of the Global Disease Control and Prevention Vaccine Market

High prevalence and growing occurrence of infectious disease are expected to drive growth of the global disease control and prevention vaccine market. According to the study published in journal Lancet Infectious Disease, between January 2004 and December 2013, around 54,984,661 cases of 45 infectious diseases were reported with average yearly incidence 417·98 per 100,000 in China. Furthermore, according to the same source, Hepatitis B and tuberculosis (TB) has high incidence rate of 81.57 and 80.33 per 100,000, respectively. Moreover, according to the World Health Organization (WHO), in 2016, around 212 million malaria cases were reported with the highest incidence in African regions.

The vaccines manufactured with innovative technologies such as recombinant technology or cell-based vaccine production is reducing the gap between demand and supply, which is expected to the global disease control and prevention vaccine market growth in the near future. For instance, in 2013, Protein Science Corporation received the U.S. Food and Drug Administration (FDA) approval for Flubok Trivalent Vaccine, produced by recombinant technology in the U.S. Moreover, in 2016, Seqirus received the U.S. FDA approval for Flucelvax Quadrivalent, cell-culture derived influenza vaccine.

Key takeaways of the Disease Control and Prevention Vaccine Market:

• The global disease control and prevention vaccine market is expected to exhibit a CAGR of 12.1% over the forecast period (2017-2025), attributed to presence of untapped and highly lucrative markets in Asia Pacific, Latin America, Middle East, and Africa
• Recombinant vaccine is expected to hold significant market share over the forecast period, owing to increasing awareness about disease prevention
• Among type, monovalent segment is expected to account for largest market share over the forecast period, owing to high rate of safety and stability of the vaccine
• Among age group, pediatric vaccine segment is expected to account for largest market share over the forecast period, attributed to increasing government initiatives for child vaccination program
• Among indication, infectious disease segment is expected to account for largest market share over the forecast period, owing to high prevalence of infectious diseases such as typhoid, measles, hepatitis, and others
• Key players operating in the global disease control and prevention vaccine market include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo

Table of Contents

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Product Type
     • Market Snippet, By Type
     • Market Snippet, By Route of Administration
     • Market Snippet, By Age Group
     • Market Snippet, By Indication
     • Market Snippet, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Governmental Initiative
   • Product Pipeline
   • Regulatory Landscape
   • PEST Analysis
   • PORTER’S Five Forces
4. Global Disease Control and Prevention Vaccines Market, By Product Type, 2015–2025, (US$ Million)
   • Introduction
     • Market Share Analysis, 2017 and 2025 (%)
     • Y-o-Y Growth Analysis, 2016–2025
     • Segment Trends
   • Live-attenuated Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
   • Inactivated Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
   • Recombinant Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
   • Toxoid Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
5. Global Disease Control and Prevention Vaccines Market, By Type, 2015–2025, (US$ Million)
   • Introduction
     • Market Share Analysis, 2017 and 2025 (%)
     • Y-o-Y Growth Analysis, 2016–2025
     • Segment Trends
   • Monovalent Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
   • Multivalent Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
6. Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2015–2025, (US$ Million)
   • Introduction
     • Market Share Analysis, 2017 and 2025 (%)
     • Y-o-Y Growth Analysis, 2016–2025
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
   • Injectable
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
7. Global Disease Control and Prevention Vaccines Market, By Age Group, 2015–2025, (US$ Million)
   • Introduction
     • Market Share Analysis, 2017 and 2025 (%)
     • Y-o-Y Growth Analysis, 2016–2025
     • Segment Trends
   • Pediatric Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
   • Adult Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
8. Global Disease Control and Prevention Vaccines Market, By Indication, 2015–2025, (US$ Million)
   • Introduction
     • Market Share Analysis, 2017 and 2025 (%)
     • Y-o-Y Growth Analysis, 2016–2025
     • Segment Trends
   • Infectious Diseases
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
   • Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
   • Other Indications
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Million)
9. Global Disease Control and Prevention Vaccines Market, By Regions, 2015–2025, (US$ Million)
   • Introduction
     • Market Share Analysis, By Region, 2017 and 2025 (%)
     • Y-o-Y Growth Analysis, By Region, 2015–2025
     • Regional Trends
   • North America
     • U.S.
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Canada
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
   • Europe
     • U.K.
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Germany
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Italy
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • France
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Spain
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Russia
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Rest of Europe
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
   • Asia Pacific
     • China
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Japan
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • India
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • ASEAN
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Australia
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • South Korea
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Rest of Asia Pacific
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
   • Latin America
     • Brazil
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Mexico
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Rest of Latin America
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
   • Africa
     • Northern Africa
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Central Africa
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • South Africa
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
   • Middle East
     • GCC Countries
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Israel
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
     • Rest of Middle East
       • Market Size and Forecast, By Product Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Type, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Route of Administration, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Age Group, 2015–2025, (US$ Million)
       • Market Size and Forecast, By Indication, 2015–2025, (US$ Million)
10. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
    • Analyst Views
11. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837